Joshua Rottner


I enjoy helping entrepreneurs turn their ideas into a business, and then advising the business as it matures from a startup all the way to a liquidity event such as an M&A sale or IPO.

Josh Rottner is a partner in Cooley’s emerging companies and venture capital group, counseling high-growth healthcare and technology companies from their formation through an IPO or M&A exit. Josh often serves as his clients’ outside corporate counsel, advising clients on startup and formation matters, corporate governance, financing transactions, mergers and acquisitions and other strategic transactions, working closely with his clients’ management teams and boards of directors to achieve their strategic goals.

Download full bio 


  • IN8bio – $40 Million IPO 

  • Jive Communications Sells to LogMeIn for $342 Million  

  • Neurala Raises $14 Million 

  • Tarveda Raises $30 Million Series D Financing 

  • Dyn Sells to Oracle 

  • View all



    Travelling and spending time with my wife Lauren, daughter Sophie and son Jack


  • Boston College Law School
    JD, cum laude, 2008

  • Bates College
    BA, Economics

Admissions & Credentials